As a second cohort graduate from the VITA Accelerator programme, GlakoLens received €90,000 as pre-seed for launching its activities in Italy. … Read More... about GlakoLens received investment from VITA Accelerator
GlakoLens
gives the ability to monitor intraocular pressure (IOP) fluctuations over an extended period,
allows doctors to formulate an earlier and more accurate diagnosis,
allows for the personalisation of drug and surgical therapeutic options.
24 HOUR IOP MONITORING
WITH A CONTACT LENS
DATA RECORD
AND PROCESSING
GLAUCOMA
2nd leading cause of blindness globally with no permanent cure
mostly caused by chronic ocular hypertension, elevated intraocular pressure (IOP)
